Neptune Competitors

Delisted . USA . 
Stock . Neptune Wellness Solutions
NEPTDelisted Stock  USD 0.13  0.01  7.14%   
Neptune Wellness Sol competes with Alpha Teknova, Phibro Animal, China Pharma, Universe Pharmaceuticals, and Sonoma Pharmaceuticals; as well as few others. The company conducts business under Personal Care Products sector and is part of Consumer Staples industry. Analyzing Neptune Wellness competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Neptune Wellness to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Neptune Wellness competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.130.130.13
Details
Intrinsic
Valuation
LowRealHigh
0.120.120.14
Details
Naive
Forecast
LowNextHigh
0.180.180.18
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.130.130.13
Details

Neptune Wellness Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Neptune Wellness and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Neptune and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Neptune Wellness Sol does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
PAHC
+ 0.76
TKNO
UPC
+ 0.75
EGRX
AKAN
+ 0.75
EGRX
AKAN
+ 0.64
SNOA
AKAN
+ 0.57
UPC
EGRX
+ 0.55
SHMN
  
High negative correlations   
AKAN
- 0.82
TKNO
AKAN
- 0.74
PAHC
UPC
- 0.74
PAHC
CPHI
- 0.68
SSIC
EGRX
- 0.63
PAHC
EGRX
- 0.62
TKNO

Risk-Adjusted Indicators

There is a big difference between Neptune Stock performing well and Neptune Wellness Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neptune Wellness' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TKNO  4.64  0.57  0.12  0.44  5.10 
(5.15)
 12.84 
(8.91)
 32.06 
PAHC  1.96  0.16  0.13  0.21  1.62 
(2.30)
 5.36 
(2.45)
 15.47 
SHMN  5.27 (0.39) 0.00 (6.31) 0.00 
 0.00 
 11.11 
(11.11)
 38.18 
SSIC  1.09  0.12  0.02  0.60  1.04 
(1.35)
 2.89 
(1.82)
 7.09 
EGRX  3.94 (1.12) 0.00  1.87  0.00 
 0.00 
 9.24 
(8.24)
 53.71 
CPHI  4.16  0.12 (0.02) 0.00  4.85 
(9.17)
 9.09 
(11.11)
 43.71 
UPC  7.66 (3.71) 0.00 (143.01) 0.00 
 0.00 
 12.27 
(16.26)
 73.25 
SNOA  5.48 (0.71) 0.00 (0.17) 0.00 
 0.00 
 13.88 
(13.23)
 40.82 
ACOR  5.60  0.99  0.17  1.10  5.26 
(6.81)
 14.01 
(9.57)
 95.04 
AKAN  3.32 (1.08) 0.00 (0.62) 0.00 
 0.00 
 4.55 
(7.22)
 22.55 
All Fundamental Data

Neptune Wellness Competitive Analysis

The better you understand Neptune Wellness competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Neptune Wellness' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Neptune Wellness' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NEPT TKNO PAHC SHMN SSIC EGRX CPHI UPC SNOA ACOR
 7.14 
 0.13 
Neptune
 0.69 
 7.33 
Alpha
 0.08 
 23.74 
Phibro
 0.00 
 0.0008 
Sohm
 1.22 
 12.96 
Silver
 1.02 
 1.99 
Eagle
 5.00 
 0.19 
China
 7.82 
 1.93 
Universe
 2.06 
 2.85 
Sonoma
 2.41 
 16.20 
Acorda
Market Volatility
(90 Days Market Risk)
Very steady
Unstable
Not too volatile
Very steady
Not too volatile
Extremely Dangerous
Out of control
Abnormally volatile
Dangerous
Very steady
Market Performance
(90 Days Performance)
Very Weak
OK
OK
Very Weak
Good
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Below Average
Low
Dangerous
Dangerous
Dangerous
Quite High
Average
Very High
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Hold
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Hold
Strong Buy
Not Rated
Not Rated
Not Rated
Hold
Strong Hold
Strong Hold
Not Rated
Current Ratio
1.7
6.76
2.97
1.22
111.63
1.78
0.75
5.06
3.05
1.71
Net Asset
41.8 M
128.59 M
982.18 M
2.91 M
88.58 M
406.16 M
16.47 M
53.29 M
14.74 M
117.75 M
Profit Margin
-1.37
-0.98
0.0166
-0.87
0.45
0.0464
-0.7
-0.69
-0.36
-2.15
EBITDA
(63.05 M)
(25.54 M)
84.61 M
(1.01 M)
7.34 M
65.48 M
8.44 K
(3.22 M)
(4.53 M)
8.4 M
Operating Margin
-2.33
-0.53
0.0811
-0.87
0.67
0.16
-1.5
-0.14
-0.35
0.039
Current Valuation
6.14 M
389.64 M
1.38 B
4.99 M
32.12 M
82.05 M
8.8 M
(1.84 M)
(17.37 K)
161.45 M
Price To Book
0.56
4.48
3.72
N/A
0.78
0.1
0.66
0.11
0.71
0.0527
Retained Earnings
(518.5 M)
(91.79 M)
243.89 M
(238.52 M)
449.27 K
111.5 M
(39.29 M)
10.16 M
(194.35 M)
(1.19 B)
Current Asset
43.08 M
N/A
342.83 M
1.75 M
N/A
119.05 M
20.99 M
N/A
12.89 M
451.32 M
Five Year Return
N/A
N/A
1.85
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
2.19
0.36
0.51
0.64
0.28
0.52
0.71
1.54
1.38
1.46
Number Of Employees
50
210
1.94 K
145
5
134
231
225
10
102
Shares Outstanding
4.53 M
53.3 M
20.34 M
N/A
6.21 M
12.96 M
19.25 M
1.58 M
1.34 M
1.24 M
Cash Flow From Operations
(38.61 M)
(18.81 M)
87.59 M
(851.19 K)
7.98 M
30.8 M
(699.69 K)
1.12 M
(2.4 M)
(13.98 M)
Annual Yield
N/A
N/A
0.0202
N/A
0.094
N/A
N/A
N/A
N/A
N/A
Total Debt
25.31 M
30.46 M
525.46 M
3.5 M
3.01 M
62.47 M
4.63 M
5.48 M
608 K
190.9 M
Return On Equity
-8.18
-0.42
0.0655
N/A
0.0641
0.0488
-0.75
-0.5
-0.75
-0.24
Z Score
-21.12
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.67
-0.15
0.0526
-0.25
0.0562
0.0663
-0.18
-0.0565
-0.2
-0.0577
Number Of Shares Shorted
25.38 K
288.2 K
404.72 K
N/A
9.78 K
350.53 K
93.6 K
281.85 K
54.67 K
8.1 K
Book Value Per Share
-6.89
2.21
6.38
-0.001
13.56
19.25
0.7
7.34
7.86
-127.17
Current Liabilities
18.39 M
N/A
108.78 M
1.4 M
N/A
35.45 M
12.95 M
N/A
3.55 M
90.59 M
Total Asset
41.8 M
128.59 M
982.18 M
2.91 M
88.58 M
406.16 M
16.47 M
53.29 M
14.74 M
117.75 M
Debt To Equity
0.27
0.27
1.79
-1.12
N/A
0.23
2.63
0.072
0.12
2.56
Short Ratio
0.61
2.03
2.28
N/A
4.63
3.91
0.22
0.08
0.22
1.84
Target Price
26.25
8.0
18.4
N/A
8.8
17.0
3.0
N/A
19.5
10.0
Last Dividend Paid
N/A
N/A
0.48
N/A
0.98
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
6.09
82.28
99.43
N/A
76.19
76.65
0.21
2.86
2.41
13.22
Market Capitalization
906.41 K
340.1 M
961.56 M
861.17 K
66.13 M
27.73 M
3.69 M
3.04 M
3.82 M
821.03 K
Price To Earning
23.48
N/A
11.39
-0.05
N/A
40.52
-0.89
3.02
2.57
0.95
Price To Earnings To Growth
N/A
N/A
1.66
N/A
N/A
0.91
N/A
N/A
N/A
0.51
Price To Sales
0.0232
10.75
0.92
0.91
5.32
0.11
0.59
0.11
0.3
0.007
Net Income
(81.71 M)
(36.78 M)
2.42 M
(1.02 M)
7.34 M
(2.67 M)
(3.08 M)
(6.16 M)
(4.83 M)
(252.85 M)
Earnings Per Share
-200.2
-0.92
0.43
-0.002
0.9
0.85
-0.69
-76.35
-0.99
-203.57
Shares Owned By Insiders
43.8
9.32
0.57
N/A
0.43
12.02
51.28
8.79
1.5
0.69
Revenue
71.11 M
36.68 M
1.02 B
1.96 M
11.72 M
316.61 M
7.01 M
32.31 M
12.73 M
117.63 M
Working Capital
(17.48 M)
36.78 M
396.85 M
353 K
N/A
77.67 M
(823.73 K)
23.06 M
8.83 M
(152.98 M)
Cash And Equivalents
6.25 M
64.73 M
98.67 M
182.56 K
60.62 M
36.56 M
2.24 M
28.58 M
5.59 M
20.7 M
Cash Per Share
0.78
2.3
2.44
N/A
9.75
2.75
0.04
1.31
1.8
0.85
Gross Profit
(8.46 M)
17.48 M
298.24 M
333.87 K
5.38 M
221.67 M
349.27 K
21.89 M
4.48 M
82.43 M
Day Typical Price
0.13
7.46
23.93
8.0E-4
13.06
2.11
0.19
1.91
2.94
15.99
Accumulation Distribution
0.0714
0.1
0.0259
N/A
0.0219
0.2
0.05
0.16
0.0955
0.0861
Market Facilitation Index
0.01
0.82
0.63
N/A
0.29
0.47
0.01
0.32
0.3
1.43
Daily Balance Of Power
(1.00)
0.061
(0.03)
0.0
(0.55)
0.0426
(1.00)
0.4375
(0.20)
(0.28)
Period Momentum Indicator
(0.01)
0.05
(0.02)
N/A
(0.16)
0.02
(0.01)
0.14
(0.06)
(0.40)
Rate Of Daily Change
0.93
1.01
1.0
1.0
0.99
1.01
0.95
1.08
0.98
0.98
Day Median Price
0.14
7.52
24.03
8.0E-4
13.11
2.17
0.2
1.9
2.99
15.89
Price Action Indicator
(0.01)
(0.17)
(0.30)
N/A
(0.22)
(0.16)
(0.01)
0.1
(0.17)
0.11
Relative Strength Index
2.33
68.05
30.42
35.47
29.17
15.37
38.24
19.43
65.0
51.58
Coefficient Of Variation
(381.57)
798.76
685.35
(2,045)
952.24
(567.97)
131782.06
(343.86)
(2,010)
1032.27
Mean Deviation
4.58
4.64
1.96
5.27
1.09
3.94
4.16
7.66
5.48
5.6
Jensen Alpha
(2.14)
0.5733
0.1588
(0.39)
0.1234
(1.12)
0.1187
(3.71)
(0.71)
0.9866
Total Risk Alpha
(3.17)
(0.22)
(0.04)
(1.57)
(0.09)
(2.26)
(1.10)
(5.70)
(1.69)
(0.71)
Sortino Ratio
N/A
0.1155
0.1291
N/A
0.0248
N/A
(0.02)
N/A
N/A
0.1663
Downside Variance
N/A
33.71
3.68
N/A
1.84
N/A
58.9
N/A
N/A
35.25
Standard Deviation
7.54
6.4
2.59
7.56
1.57
6.74
6.92
12.7
8.1
11.54
Kurtosis
18.62
2.69
2.42
0.0441
3.42
16.35
4.07
10.57
2.48
30.45
Potential Upside
5.88
12.84
5.36
11.11
2.89
9.24
9.09
12.27
13.88
14.01
Treynor Ratio
(1.52)
0.4378
0.2122
(6.31)
0.6011
1.87
0.0046
(143.01)
(0.17)
1.1
Maximum Drawdown
53.24
32.06
15.47
38.18
7.09
53.71
43.71
73.25
40.82
95.04
Variance
56.9
41.0
6.73
57.12
2.45
45.47
47.95
161.34
65.59
133.16
Market Risk Adjusted Performance
(1.51)
0.4478
0.2222
(6.30)
0.6111
1.88
0.0146
(143.00)
(0.16)
1.11
Risk Adjusted Performance
(0.19)
0.1048
0.1189
(0.03)
0.0856
(0.13)
0.0095
(0.21)
(0.03)
0.0836
Skewness
(3.58)
0.7645
1.12
0.1296
1.06
(2.65)
1.14
(2.15)
0.3598
4.75
Semi Deviation
N/A
5.1
1.62
N/A
1.04
N/A
4.85
N/A
N/A
5.26
Information Ratio
(0.28)
0.1048
0.0955
(0.07)
0.0215
(0.20)
(0.02)
(0.30)
(0.07)
0.0855
Value At Risk
(10.53)
(8.91)
(2.45)
(11.11)
(1.82)
(8.24)
(11.11)
(16.26)
(13.23)
(9.57)
Expected Short fall
N/A
(5.15)
(2.30)
N/A
(1.35)
N/A
(9.17)
N/A
N/A
(6.81)
Downside Deviation
N/A
5.81
1.92
N/A
1.36
N/A
7.67
N/A
N/A
5.94
Semi Variance
N/A
25.99
2.62
N/A
1.08
N/A
23.56
N/A
N/A
27.67

Neptune Wellness Competition Performance Charts

Five steps to successful analysis of Neptune Wellness Competition

Neptune Wellness' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Neptune Wellness Sol in relation to its competition. Neptune Wellness' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Neptune Wellness in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Neptune Wellness' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Neptune Wellness Sol, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Neptune Wellness position

In addition to having Neptune Wellness in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks
Macroaxis Picks Theme
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Neptune Stock

If you are still planning to invest in Neptune Wellness Sol check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neptune Wellness' history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY